DAWN - CIK 0001845337
Day One Biopharmaceuticals, Inc. (DAWN) reported revenue of $158.18M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $158.18M | +20.6% |
| FY 2024 | $131.16M | - |
| FY 2023 | $0.00 | - |
| FY 2022 | $0.00 | - |
Day One Biopharmaceuticals, Inc. (DAWN) reported revenue of $158.18M for fiscal year 2025, as filed in its audited annual report with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.